Trial intelligence / Profile preview

Topical potassium hydroxide 15% for common warts

IRCT2014081118765N1Phase 3Completed

Sponsor
Ahvaz Jundishapur University of Medical Sciences
Start
Sep 2012
Modality
Small Molecules
Countries
1
01

Overview

Phase 3, open-label, single-arm trial of potassium hydroxide in common wart, sponsored by Ahvaz Jundishapur University of Medical Sciences. Started Sep 2012; status: completed.

02

Drugs

potassium hydroxide
03

Conditions

common wart

Beyond the preview

Go deeper on IRCT2014081118765N1.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on IRCT2014081118765N1.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call